Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
10/2010
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010CA2436233C Perylenequinones for use with immunotherapy agents
09/2010
09/30/2010US20100249218 Method to inhibit cell growth using oligonucleotides
09/30/2010US20100247447 Drug delivery system for hydrophobic drugs
09/29/2010EP2231188A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis
09/29/2010CN101843583A Quantum dot iodized oil dispersion and preparation method and use thereof
09/29/2010CN101843578A Nanofiber membrane carrying anti-tumor photosensitizer and preparation method thereof
09/28/2010US7803350 Radioactive arsenic-containing compounds and their uses in the treatment of tumors
09/28/2010CA2577441C Improved photosensitizer formulations and their use
09/28/2010CA2464758C Combination therapy comprising zd6474 and a taxane
09/23/2010WO2010107990A1 Compositions and methods for enhancing contrast in imaging
09/23/2010WO2010107454A1 Composition for photodynamic disinfection
09/23/2010WO2010105361A1 Oct guided tissue ablation
09/23/2010CA2755998A1 Compositions and methods for enhancing contrast in imaging
09/23/2010CA2754982A1 Composition for photodynamic disinfection
09/22/2010EP2229182A2 Polymeric drug carrier for image-guided delivery
09/22/2010CN1893961B Biologically active blood serum obtained by electroshock
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/15/2010EP2227474A1 Azo and diaza derivatives and uses thereof in phototherapy
09/15/2010CN101835556A Gold nanoparticle composition, DNA chip, near infrared absorbent, drug carrier for drug delivery system (DDS), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use
09/15/2010CN101829326A Use of microbubbles with high-intensity cavitation generated by combining ultrasonic in preparation of anti-tumor neovascularization medicaments
09/15/2010CN101829112A Medicinal use and preparation of compound
09/10/2010WO2010102183A1 Methods of enhancing peroxide activity
09/10/2010CA2754840A1 Methods of enhancing peroxide activity
09/08/2010EP2226318A2 Dye-Azide compounds for dual photherapy
09/07/2010US7790144 Receptor-avid exogenous optical contrast and therapeutic agents
09/07/2010CA2490326C Photodynamic therapy for vascular diseases
09/07/2010CA2474448C Inactivation of west nile virus and malaria using photosensitizers
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/01/2010EP2223758A2 Method for producing polymer coating on particle surfaces
09/01/2010EP2222277A1 Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
09/01/2010EP1864683B1 Radiotherapy enhancer
09/01/2010EP1583525B1 Use of porphyrin synthesis substances in combination with salicylates and antioxidants for use in phototherapy to cure skin and articulation diseases
08/2010
08/26/2010WO2010096828A1 Multi-modality nanoparticles having optically responsive shape
08/26/2010US20100217212 Microporation of Tissue for Delivery of Bioactive Agents
08/26/2010US20100215773 Use of Quinazoline Derivative ZD6474 Combined With Platinum Compounds and Optionally Ionising Radiation in the Treatment of Diseases Associated With Angiogenesis and/or Increased Vascular Permeability
08/25/2010EP2220145A2 Polymeric composition, method for the manufacture of the polymeric composition, articles based on this polymeric composition and use of these articles
08/25/2010EP1648465B1 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
08/25/2010CN101810858A Microcrystalline glass microspheres with magnetism and radioactivity, preparation method and application thereof
08/24/2010US7780952 Distinguish between tumor cells and normal cells using novel contrast agents that contain a Magnetic Resonance Imaging (MRI) detectable moiety bound, optionally through a spacer, to a (pseudo)nutrient such as glucose, a natural or unnatural amino acid such as agmatine, or a polyamine such as spermidine
08/24/2010CA2329320C Chlorin and bacteriochlorin-based aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
08/19/2010WO2010093528A2 On-demand and reversible drug release by external cue
08/19/2010WO2010092534A1 Compositions for the treatment of aphthous stomatitis
08/19/2010US20100209409 Method for suppressing immune system response to transplanted tissue or cells
08/18/2010EP2217227A2 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
08/18/2010CN1744906B Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method
08/18/2010CN101804050A Treatment of proliferative diseases with epothilone derivatives and radiation
08/17/2010US7776828 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production
08/17/2010US7776310 non-polymeric biodegradable implantable seeds
08/17/2010CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
08/17/2010CA2144527C Up-converting reporters for biological and other assays using laser excitation techniques
08/11/2010EP2214495A1 Natural photodynamic agents and their use
08/10/2010US7772179 which binds to cell through ligand and activated by emitted light; photosensitizer is hematoporphyrin; transport ligand is peptide; conjugate of transferrin-hematoporphyrin which destroys cancerous cells in presence of luminol; tissue targeted
08/05/2010WO2010085876A1 Thylakoids and their functional derivatives, and their uses
08/05/2010US20100197779 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
08/05/2010US20100196989 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
08/05/2010US20100196988 Bioreactive Agents
08/04/2010CN101795672A Liposome formulations of boronic acid compounds
08/04/2010CN101795671A Liposome compositions for in vivo administration of boronic acid compounds
08/03/2010US7767232 Control of nitric oxide bioactivity by perfluorocarbons
08/03/2010US7767208 Noninvasive vascular therapy
08/03/2010US7767194 Using cyanine dyes; in situ supplying to tumor cells
07/2010
07/29/2010WO2010085651A1 In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles
07/29/2010US20100189824 Triterpene compositions and methods for use thereof
07/28/2010EP2210956A2 Method to inhibit cell growth using oligonucleotides
07/28/2010EP2209801A2 Manufacture, compositions and uses of coagulationfactor viia modulator
07/28/2010CN101785784A Compound of gold nanorods and zwitter ion molecules for photo-thermal therapy of cancer and preparation method thereof
07/27/2010CA2449031C Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
07/22/2010US20100183735 Method for inducing selectively suppressed immune response to transplanted tissue or cells
07/20/2010US7759526 Pharmaceutical compositions comprising cannabidiol derivatives
07/20/2010US7758871 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin
07/20/2010US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions
07/20/2010US7758561 Microporation of tissue for delivery of bioactive agents
07/20/2010CA2411831C Pharmaceutical compositions comprising cannabidiol derivatives
07/15/2010WO2010078941A1 Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy
07/15/2010WO2009156743A3 Magnetic microbubbles, methods of preparing them and their uses
07/15/2010US20100179142 Cancer Combination Therapy Comprising AZD2171 and ZD1839
07/14/2010EP2205282A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
07/13/2010US7753943 Reduced fluence rate PDT
07/13/2010CA2448303C Biologically active methylene blue derivatives
07/08/2010WO2010078028A1 Modified pyrazine derivatives and uses thereof
07/08/2010WO2010078025A1 Modified pyrazine derivatives and uses thereof
07/08/2010US20100174222 Method and apparatus for acne treatment using low intensity light therapy
07/08/2010CA2747454A1 Modified pyrazine derivatives and uses thereof
07/08/2010CA2747402A1 Modified pyrazine derivatives and uses thereof
07/06/2010US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
07/06/2010CA2484664C Green porphyrin loaded nanoparticles and their use in photodynamic therapy
07/06/2010CA2295572C Treatment of inflammatory disorders of the bowel and urinary bladder
07/01/2010CA2748155A1 Enema preparations and their use
06/2010
06/30/2010EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents
06/30/2010EP1411927B1 Method for the preparation of selectively-substituted corroles and new substituted corroles
06/30/2010EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease
06/30/2010CN101757608A Application of phycobiliprotein in preparation of photosensitizer for treating oral and pharyngeal cancer cell by using iodine-tungsten lamp
06/29/2010CA2415280C Use of halogenated xanthenes as anti-cancer and anti-bacterial agents
06/29/2010CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment
06/29/2010CA2225470C Method and apparatus for inactivating contaminants in blood products
06/24/2010WO2010070292A1 A composition for use on skin and wound
06/24/2010WO2010069073A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature
06/24/2010CA2747219A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature
06/24/2010CA2745059A1 A composition for use on skin and wounds
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 95